Skip to main content
Premium Trial:

Request an Annual Quote

Cleveland Clinic Gets FDA Emergency Use Authorization for Molecular COVID-19, Flu Combo Test

NEW YORK — The US Food and Drug Administration this week granted Emergency Use Authorization for the Cleveland Clinic's SelfCheck Cobas SARS-CoV-2 + Flu Assay.

The PCR-based test uses Roche's Cobas SARS-CoV-2 & Influenza A/B test, which received EUA from the FDA in late 2020. It is designed for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus RNA in anterior nasal swab specimens that are self-collected at home using the SelfCheck Nasal Swabbing Kit.

Use of the test is limited to the Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute, according to the FDA.

In late 2021, the Cleveland Clinic received EUA from the FDA for the SelfCheck Cobas SARS-CoV-2 Assay, which is designed to detect the SARS-CoV-2 genes in anterior nasal swab specimens self-collected using the SelfCheck COVID-19 Swabbing Kit.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.